OPTNOptinose Inc

$7.94
$0.34 (4%)

Optinose Inc (OPTN) Stock Analysis

Create a FREE Account to View Full OPTN Stock Report

Optinose Inc (OPTN) Analyst Forecast

Next 12 months ➝Current Price$7.9352-week High$11.6652-week Low$4.44MEAN$24.20+204.98%HIGH$27.00+240.26%LOW$21.00+164.65%
  • Last Price$7.94
  • Previous Close$7.59
  • Change $0.34
  • Open$7.57
  • Volume49,567
  • Avg. Volume (100-day)233,313
  • Market Capitalization$368.73M
  • Days Range $7.57 - $7.96
  • 52-week Range $4.44 - $11.66
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-2.69
  • Earnings Date03/04/2020
  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec.
  • Beta0.651
  • PEG Ratio
  • Volatility0.82
  • Average True Range0.06
OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhalation delivery system, to deliver a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.